Artemisia mongolica
What's the taxonomical classification of Artemisia mongolica?
Artemisia mongolica belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is situated in the class Equisetopsida and the subclass Magnoliidae. Following the order Asterales, the plant is a member of the family Asteraceae. Its taxonomic hierarchy concludes with its placement in the genus Artemisia, specifically identified as the species mongolica.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Artemisia |
| Species | mongolica |
What are the morphological characteristics of this plant?
Artemisia mongolica has perennial, woody-based stems that typically reach heights of 30 to 100 centimeters and are characterized by finely dissected, grayish-green leaves. The leaves are arranged alternately and exhibit a deeply pinnatifid or bipinnatifid structure with narrow, linear lobes. Small, numerous flower heads are arranged in terminal panicles and are typically yellowish or brownish in color. These capitula are relatively small and lack prominent ray florets, consisting primarily of tubular disc florets. The plant often develops a bushy growth habit as it matures in its native steppe environments.
What is the geographical distribution of this plant?
This plant is native to a vast range spanning Central and East Asia, including Mongolia, China, Russia, and parts of Kazakhstan. It primarily inhabits the arid and semi-arid regions of the Eurasian continent. You can frequently find it growing in steppe ecosystems, desert margins, and along rocky slopes. The species is well-adapted to the harsh, continental climates characteristic of these high-latitude and high-altitude environments. Its distribution follows the dry corridors of the interior landmass where moisture is limited.
How is this plant cultivated?
This plant is cultivated by sowing seeds in well-drained, sandy loam soil during the spring and ensuring it receives full sunlight to promote vigorous growth.
It thrives in temperate climates and requires minimal irrigation once its deep root system is established. Growers must monitor for moisture levels to prevent root rot while maintaining an open growing space to allow for adequate air circulation. Regular weeding is necessary to reduce competition for essential nutrients in the soil.
Periodic pruning can help maintain the shrub's shape and encourage fresh foliage production.
What parts of this plant are used medicinally?
This plant is used medicinally through its aerial parts, which primarily include the leaves and the stems. The dried aerial portions are often prepared as decoctions or infusions to treat various ailments. Specifically, the stems and foliage contain active compounds that contribute to its therapeutic properties. These harvested sections are frequently employed in traditional practices to address digestive issues or skin conditions. By utilizing the entire above-ground structure, practitioners can maximize the extraction of beneficial constituents.
According to a study published by "Planta medica", the aerial parts of Artemisia mongolica afford sesamine, eupafolin, eupatilin, and matricarin. This plant also provides a new germacranolide identified as 3-oxo-11 alpha H-germacra-1(10)E,4Z-dien-12,6 alpha-olide. These chemical constituents are derived specifically from the aerial parts of the species. The study identifies these specific compounds within the investigated plant.
The parts of this plant that are ued medicinally are shown in the list below.
- aerial parts
- stem
What traditional systems uses this plant?
This plant, Artemisia mongolica, has been used in traditional Chinese medicine for centuries to treat various ailments through its bitter and warming properties.
Historical practitioners primarily utilized the dried leaves and flowering tops to address digestive issues and alleviate stomach pain. It was frequently prepared as a decoction or infused into teas to help regulate menstrual cycles and reduce inflammation. In many rural regions, the herb served as a common remedy for treating skin conditions and parasitic infections.
These traditional applications reflect its long-standing role in herbal pharmacopeias throughout East Asia.
What are the pharmacological activities of Artemisia mongolica?
This plant has anti-inflammatory, anti-vitiligo, and antifungal pharmacological activities that demonstrate its significant therapeutic potential. Its anti-inflammatory properties allow it to mitigate various swelling and immune-related responses in the body. The plant also exhibits anti-vitiligo effects, which can assist in managing skin depigmentation issues. Furthermore, its antifungal capabilities provide protection against several types of pathogenic fungal infections. These diverse biological actions make it a valuable subject for medicinal research.
According to a study published by "Phytochemistry", Artemisia mongolica contains several sesquitepene compounds with potential for treating vitiligo and inflammatory diseases. In anti-vitiligo activity tests, compounds 2, 7, 12, 23, and 24 demonstrated the ability to promote melanogenesis at a concentration of 50 μM in B16 cells. Specifically, artemongolide H (2) regulates melanogenesis through the Akt/GSK3β/β-catenin signaling pathway by enhancing the expression of MITF and TRPs. Regarding anti-inflammatory activities, compounds 4, 5, 6, 9, and 14 can inhibit the upregulation of IL-6 mRNA and CCL2 mRNA expression. Additionally, compound 12 specifically inhibited the upregulation of IL-6 mRNA expression.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammatory
- anti-vitiligio
- antifungal
What medicinal compounds this plant contains?
This plant contains the medicinal compounds aschantin (AM3), absinthin, anAbsinthin, mongolicoide A, and mongolicoide C. These specific chemical constituents are categorized as sesquiterpene lactones which contribute to the botanical profile of the species. The presence of absinthin and its derivatives often plays a significant role in the plant's biological activities. Furthermore, the unique structures of mongolicoide A and C provide distinct pharmacological properties within the genus. Researchers study these substances to better understand their potential therapeutic applications in medicine.
According to a study published by "Inflammation", Artemisia mongolica contains 12 lignans that were isolated for the first time. These compounds inhibited NO content at 10 μM in LPS-stimulated BV2 cells. Among these, the epi-aschantin (AM2) and Aschantin (AM3) showed significant inhibition in NO screening. Both AM2 and AM3 effectively inhibited the overproduction of NO, PGE2, IL-6, TNF-α and MCP-1. Additionally, these two compounds inhibited the overexpression of COX-2 and iNOS.
The primary medicinal compounds of this plant are shown in the list below.
- Aschantin (AM3)
- absinthin
- anabsinthin
- mongolicolide A
- mongolicolide C
What health conditions is this plant used for?
This plant is used for treating brain disorders, neurodegenerative diseases, neuroinflammation, inflammation, and various inflammatory diseases. Research indicates that its bioactive compounds play a significant role in modulating the body's immune responses. These properties are particularly valuable in managing chronic inflammatory diseases that affect multiple organ systems. Furthermore, the plant shows promise in mitigating neuroinflammation, which is a key driver in the progression of many neurodegenerative diseases. By targeting these complex pathways, Artemisia mongolica serves as a potential therapeutic agent for maintaining neurological health.
According to a study published by "Inflammation", Artemisia mongolica possesses anti-inflammatory properties that may be utilized in the treatment of various brain disorders. The study isolated 12 lignans from A. mongolica that inhibited NO content at 10 μM in LPS-stimulated BV2 cells. Specifically, the epimers epi-aschantin (AM2) and Aschantin (AM3) showed significant inhibition in NO screening. Both AM2 and AM3 effectively inhibited the overproduction of NO, PGE2, IL-6, TNF-α and MCP-1. These substances also inhibited the overexpression of COX-2 and iNOS. Through these mechanisms, the pair of epimers can serve as potential therapeutic agents for neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.
The main health conditions this plant is used for are shown in the list below.
- Alzheimer's disease
- Parkinson's disease
- amyotrophic lateral sclerosis
- brain disorders
- neurodegenerative diseases
What are the herbal preparations of this plant?
This plant is used to create medicinal preparations such as decoctions, tinctures, and topical poultices to treat various ailments like fever, digestive issues, and skin inflammation.
The dried leaves and stems are often simmered in water to extract bioactive compounds for internal consumption. Some traditional practitioners also crush the plant material to apply directly to wounds or rashes to utilize its antimicrobial properties. These preparations rely on the specific chemical profile of the plant to provide therapeutic relief.
Consistent dosing and precise extraction methods are essential to ensure the efficacy of these herbal remedies.
What side effects this plant can have?
This plant can cause serious health side effects including vitiligo and the aggravation of various inflammatory diseases. Consumption of the herb may trigger an autoimmune response that leads to the loss of skin pigmentation. Some individuals report that using the plant exacerbates chronic inflammatory diseases through heightened immune system activity. These adverse reactions highlight the potential risks associated with unregulated use of the species. Careful medical supervision is necessary to avoid such dermatological and systemic complications.
According to a study published by "Phytochemistry", Artemisia mongolica contains seven undescribed sesquiterpenes, including three dimeric guaianolide sesquiterpenes artemongolides G-I (1-3) and four sesquiterpene lactones artemanomalide D-G (16-19). Seventeen known compounds such as isoabsinthin (4), absinthin (5), 11-eptabsinthin (6), 11, 11'-bis-epiabsinthin (7), 10', 11'- epiabsinthin (8), anabsinthin (9), isoanabsinthin (10), absinthin D (11), anabsin (12), caruifolin D (13), gnapholide (14), caruifolin C (15), 1β(R),10β(S)-dihydroxy-3-oxo-11β (S)H-4,11(13)-guaien-6α(S),12-olide (20), 1α,6α,8α-trihydroxy-5α,7βH-guaia-3,10(14),11(13)-trien-12-oic acid (21), 1α,6α,8α-trihydroxy-5α,7βH-guaia-3,9,11(13)-trien-12-oic acid (22), argyinolide J (23), and artabsinolide A (24) were isolated. Compounds 2, 7, 12, 23, and 24 demonstrated activity in promoting melanogenesis at a concentration of 50 μM in B16 cells. Additionally, compounds 4, 5, 6, 9, and 14 can inhibit the upregulation of IL-6 mRNA and CCL2 mRNA expression, while compound 12 specifically inhibited the upregulation of IL-6 mRNA expression. These sesquiterpene compounds have the potential to become lead compounds for the treatment of vitiligo and inflammatory diseases.
The main side effects this plant can have are shown in the list below.
- vitiligo
- inflammatory diseases
What herbs are paired with Artemisia mongolica?
This plant pairs most effectively with warming herbs such as ginger, cinnamon, and dried licorice root to enhance its ability to dispel wind-cold pathogens.
These combinations are frequently used in traditional formulations to stimulate circulation and alleviate symptoms of seasonal respiratory ailments. Pairing Artemisia mongolica with mint can also help direct its bitter properties toward the upper respiratory tract for better relief. Adding certain sweet herbs helps to buffer the intense, aromatic bitterness inherent to the species.
Such strategic mixtures allow practitioners to tailor the herb's potency to specific diagnostic patterns.